Trials / Completed
CompletedNCT05123196
Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy
A Randomized, Double-Blind, Placebo-Controlled, Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 156 (actual)
- Sponsor
- Tanabe Pharma Corporation · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the efficacy, safety, tolerability and pharmacokinetics of MT-8554, compared to placebo, in subjects with painful diabetic peripheral neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MT-8554 | Oral Capsule |
| DRUG | Placebo | Oral Capsule |
Timeline
- Start date
- 2021-11-16
- Primary completion
- 2022-11-01
- Completion
- 2022-11-08
- First posted
- 2021-11-17
- Last updated
- 2025-12-22
Locations
33 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT05123196. Inclusion in this directory is not an endorsement.